Life sciences news
-
flanders.bio applauds New Genomic Techniques European Parliament vote, while issuing cautionary note
Thursday February 8th 2024
Read more
-
Biotalys enters into academic collaborations with key scientific leaders in Europe and U.S.
Thursday February 8th 2024
Read more
-
Belgian researchers provide a strong boost to sustainable agriculture
Thursday February 1st 2024
Read more
-
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
Thursday February 1st 2024
Read more
-
BioLizard announces the appointment of André van de Sande as Chairman of the Board
Tuesday January 30th 2024
Read more
-
Sequana Medical announces FDA acceptance for substantive review of the Premarket Approval application for alfapump® in recurrent or refractory ascites due to liver cirrhosis
Monday January 29th 2024
Read more
-
Fruit flies provide insights into the hidden world of sleep
Tuesday January 23rd 2024
Read more
-
Protealis secures EUR 22 million in oversubscribed B-round funding to propel sustainable plant protein seed solutions
Tuesday January 23rd 2024
Read more
-
Become a flanders.bio member
Your news here?
-
flanders.bio celebrates 20 years of catalysing growth in life sciences
Tuesday January 23rd 2024
Read more
-
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure
Tuesday January 23rd 2024
Read more
-
argenx announces approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) injection for subcutaneous use in Japan for generalized myasthenia gravis
Wednesday January 17th 2024
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
